Neuropace, Inc. NPCE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$6.69M-1.5% | -$2.73M+48.0% | -$3.5M+35.9% | -$8.65M-15.1% | -$6.59M+26.2% | ||
| $60K+22.4% | $80K+66.7% | $100K0.0% | $100K0.0% | $49K+8.9% | ||
| $2.28M-13.3% | $2.61M+0.2% | $2.63M+1.4% | $3.23M+26.7% | $2.63M+3.4% | ||
| $68K+38.8% | $63K+28.6% | $70K+48.9% | $55K+1.9% | $49K-37.2% | ||
| $0+100% | -$12K— | —— | —— | -$2K— | ||
| $108K-95.8% | —— | $1.38M+335% | —— | $2.59M+479% | ||
| -$125K-151% | —— | $1.84M+122% | $2.82M— | $243K-2.4% | ||
| $2.2M+127% | -$2.39M-409% | -$48K+63.1% | $737K— | $966K+1.7% | ||
| -$4M-71.2% | $1.02M+460% | $2.65M— | $2.21M— | -$2.33M+40.0% | ||
| $77K+151% | -$809K— | —— | -$521K-193% | -$150K+68.4% | ||
| -$15K-112% | -$507K-163% | -$48K+21.3% | $17K+128% | $124K+156% | ||
| $453K+9.7% | $442K+9.7% | $433K+9.6% | $422K+9.3% | $413K+9.3% | ||
| -$513K-14.0% | -$480K-14.3% | -$469K-14.1% | -$461K-14.7% | -$450K-14.2% | ||
| -$5.9M+21.1% | $0+100% | -$1.94M-12.8% | -$2.09M+46.5% | -$7.48M+0.6% | ||
| $117K+216% | $97K+149% | $30K-70.0% | $168K+167% | $37K-64.4% | ||
| -$117K-216% | -$97K-105% | -$30K-102% | -$168K-105% | -$37K-102% | ||
| $0-100% | —— | —— | —— | $49.55M— | ||
| $10K-97.4% | $723K+21.5% | $1K-97.1% | $766K+31.8% | $385K-46.6% | ||
| $176K-22.8% | $88K-4.3% | $53K-22.1% | $174K+142% | $228K-64.9% | ||
| -$166K-101% | $635K-25.1% | —— | —— | $21.11M+29,217% | ||
| -$6.18M-146% | $1.04M+153% | —— | —— | $13.59M+369% | ||
| $1.39M-26.6% | $1.46M-24.4% | $1.46M-24.5% | $1.39M+16.7% | $1.89M+61.0% | ||
| $68K+38.8% | $63K+28.6% | $70K+48.9% | $55K+1.9% | $49K-37.2% | ||
| $60K+22.4% | $80K+66.7% | $100K0.0% | $100K0.0% | $49K+8.9% | ||
| -$165K-101% | —— | $82K-62.6% | —— | -$82K-261% | ||
| $77K-63.8% | $75K-64.5% | $73K-64.0% | $177K-21.0% | $213K-32.6% | ||
| -$513K-14.0% | -$480K-14.3% | -$469K-14.1% | -$461K-14.7% | -$450K-14.2% | ||
| $77K+151% | -$809K— | —— | -$521K-193% | -$150K+68.4% | ||
| $76K+72.7% | $19K-65.5% | $47K-56.1% | $49K+16.7% | $44K-6.4% | ||
| $453K+9.7% | $442K+9.7% | $433K+9.6% | $422K+9.3% | $413K+9.3% | ||
| —— | —— | —— | —— | —— | ||
| $10K-97.4% | $723K+21.5% | $1K-97.1% | $766K+31.8% | $385K-46.6% | ||
| $114K-19.1% | $12K-36.8% | —— | —— | $141K+156% | ||
| $0-100% | —— | —— | —— | $277K— | ||
| $0-100% | —— | —— | —— | $611K— | ||
| -$15K-112% | -$507K-163% | -$48K+21.3% | $17K+128% | $124K+156% | ||
| -$513K-14.0% | -$480K-14.3% | -$469K-14.1% | -$461K-14.7% | -$450K-14.2% | ||
| -$6.02M+20.0% | $0+100% | -$1.97M-8.2% | -$2.25M+43.1% | -$7.52M+1.5% | ||
| -$6.02M+20.0% | $0+100% | -$1.97M-8.2% | -$2.25M+43.1% | -$7.52M+1.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Neuropace, Inc. generate?
- Neuropace, Inc. (NPCE) generated -$9.9M in operating cash flow over the trailing twelve months.
- What is Neuropace, Inc.'s free cash flow?
- After $412.0K of capital expenditures, Neuropace, Inc.'s free cash flow was -$10.2M over the trailing twelve months, up 43.5% year over year.
- Where does Neuropace, Inc.'s cash flow data come from?
- Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
